血管紧张素II

✍ dations ◷ 2025-12-01 15:45:41 #血管紧张素II
1N9U, 1N9V, 2JP8, 2WXW, 2X0B· hormone activity · hormone activity · protein binding · growth factor activity · acetyltransferase activator activity · type 1 angiotensin receptor binding· extracellular region · extracellular region · extracellular space · extracellular space · extracellular space · soluble fraction· regulation of cell growth · blood vessel development · positive regulation of cytokine production · kidney development · blood vessel remodeling · angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure · renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure · regulation of blood volume by renin-angiotensin · renin-angiotensin regulation of aldosterone production · regulation of renal output by angiotensin · regulation of blood vessel size by renin-angiotensin · brain renin-angiotensin system · cellular sodium ion homeostasis · cell-matrix adhesion · G-protein coupled receptor protein signaling pathway · G-protein signaling, coupled to cGMP nucleotide second messenger · activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger · nitric oxide mediated signal transduction · cell-cell signaling · excretion · establishment of blood-nerve barrier · regulation of blood pressure · negative regulation of cell proliferation · response to cold · response to salt stress · positive regulation of activation of JAK2 kinase activity · positive regulation of endothelial cell migration · positive regulation of cardiac muscle hypertrophy · positive regulation of macrophage derived foam cell differentiation · positive regulation of cholesterol esterification · negative regulation of endopeptidase activity · regulation of norepinephrine secretion · positive regulation of phosphatidylinositol 3-kinase cascade · response to muscle activity involved in regulation of muscle adaptation · regulation of vasoconstriction · regulation of proteolysis · extracellular matrix organization · negative regulation of cell growth · peristalsis · positive regulation of cellular protein metabolic process · positive regulation of NAD(P)H oxidase activity · low-density lipoprotein particle remodeling · positive regulation of multicellular organism growth · regulation of cell proliferation · hormone metabolic process · drinking behavior · positive regulation of apoptosis · positive regulation of catalytic activity · positive regulation of MAPKKK cascade · negative regulation of neuron apoptosis · cellular lipid metabolic process · positive regulation of fatty acid biosynthetic process · positive regulation of epidermal growth factor receptor signaling pathway · positive regulation of transcription, DNA-dependent · positive regulation of organ growth · astrocyte activation · positive regulation of fibroblast proliferation · regulation of long-term neuronal synaptic plasticity · smooth muscle cell proliferation · positive regulation of inflammatory response · positive regulation of peptidyl-tyrosine phosphorylation · positive regulation of NF-kappaB transcription factor activity · smooth muscle cell differentiation · negative regulation of nerve growth factor receptor signaling pathway · positive regulation of protein tyrosine kinase activity · positive regulation of branching involved in ureteric bud morphogenesis血管收缩素(Angiotensin),亦称血管紧张素、血管张力素,是一种寡肽类激素,是肾素-血管收缩素系统(renin-angiotensin system)的重要组成部分。血管紧张素能引起血管收缩,升高血压;促进肾上腺皮质释放醛固酮。它也具有很强的致渴作用。血管紧张素的前体是由肝脏合成的一种血清球蛋白:血管紧张素原。血管紧张素最早于20世纪30年代末由美国印第安纳和阿根廷的研究人员分别独立分离,并被分别命名为Angiotonin和Hypertensin,后来被美国克利夫兰诊所和瑞士巴塞尔的汽巴实验室(Ciba Laboratories)描述并合成。血管紧张素原是一种主要由肝脏持续合成并释放入血液循环的α-2球蛋白。它属于丝氨酸蛋白酶抑制物超家族(serine protease inhibitors,serpin),虽然就目前所知它不能抑制任何酶的活性。皮质激素、雌激素、甲状腺素和血管紧张素II可增高血浆血管紧张素原含量。血管紧张素原是肾素的底物。人血管紧张素原包含452个氨基酸残基,而其他物种的血管紧张素原大小有所不同。它的N-端12个氨基酸残基由于关系到其活性而最为重要。血管紧张素Ⅰ由肾素作用于血管紧张素原形成。肾素能催化血管紧张素原亮氨酸(Leu)与缬氨酸(Val)间的肽键水解产生十肽血管紧张素I;血管紧张素Ⅰ基本没有生物学活性,而是作为血管紧张素Ⅱ的前体存在。血管紧张素I经血管紧张素Ⅰ转化酶剪切C-末端两个氨基酸残基而形成血管紧张素Ⅱ。血管紧张素II是一种可通过内分泌、自分泌/旁分泌以及胞内分泌发挥作用的激素。血管紧张素Ⅱ通过血管紧张素酶降解为血管紧张素Ⅲ,其在循环系统的半衰期约为30秒,而在组织中最长可达15至30分钟。相比较血管紧张素Ⅱ而言,血管紧张素Ⅲ(七肽)仍具有40%的升压活性和100%的促醛固酮分泌活性。血管紧张素Ⅳ(六肽)与血管紧张素Ⅲ相似,而活性更低。Template:Angiotensin receptor modulators(英语:Template:Angiotensin receptor modulators)

相关

  • 鬼臼毒素鬼臼毒素,也称普达非洛,是一种一个非生物碱类木脂素类毒素。它提取自鬼臼的根茎。它的乙醇溶液和软膏的商品名分别为慷定来和化疣敌,可作为外用药物用于治疗由人类乳头瘤病毒引
  • 肾衰竭肾功能衰竭(英语:renal failure、kidney failure,或renal insufficiency),又简称肾衰竭,是指因肾病变,造成肾脏出现问题导致未能有效带走血液中的杂质,继而影响身体的代谢,严重者可致
  • 布宜诺斯艾利斯大学布宜诺斯艾利斯大学(西班牙语:Universidad de Buenos Aires,UBA)是阿根廷最大的大学,创立于1821年8月12日。它由13个院系、六家医院、10个博物馆和3所中学组成。下列学院组成的大
  • 霰粒肿霰粒肿(英语:chalazion),又称睑板腺囊肿,是因为皮脂腺堵塞造成的眼睑囊肿,一般会在眼睑中间,会发红,不过不会疼痛。多半会持续出现几周。会长出霰粒肿的原因可能是先前已罹患针眼或
  • 运动防护员运动防护员(英语:Athletic Trainer,简称AT),又称运动训练员,是一种需考取专业证照之运动医学专业人员,专门从事运动防护以及运动训练等等工作。其中,运动防护是指各种体育运动之预防
  • 氮化镁氮化镁(Mg3N2)是由氮和镁所组成的无机化合物。在室温下纯净的氮化镁为黄绿色的粉末,但含有一部分氧化镁杂质的氮化镁是灰白色的。氮化镁和许多金属氮化物一样,会和水反应产生氨
  • 叶 (解剖学)解剖学上的叶(lobe)是指在不用显微镜的巨观尺度下,器官就呈现的明确部位划分,有分叶的器官像是脑、肺、肝脏或肾。叶和小叶(lobule)不同,后者只能在组织学中只能看出其划分。腺叶间
  • USA Today《今日美国》(英语:USA Today)是美国唯一的彩色版全国性对开日报,1982年9月15日创刊,总部设在弗吉尼亚州费尔法克斯县的麦克林(McLean),属全美最大的甘尼特(Gannett)报团。《今日美国
  • 希夫试剂席夫试验(Schiff test),由德国化学家雨果·席夫(Hugo Schiff)发明的一种检验醛类的方法,与醛类反应会呈现紫红色。Schiff试剂由碱性品红与亚硫酸氢钠两种主要的化合物组成。碱性品
  • 镍过敏3d8 4s2 或 3d9 4s12, 8, 16, 2 或 2, 8, 17, 1蒸气压第一:737.1 kJ·mol−1 第二:1753.0 kJ·mol−1 第三:3395 kJ·mol−1 (主条目:镍的同位素.mw-parser-output ruby.zy{